135
Views
9
CrossRef citations to date
0
Altmetric
Articles

Ultrasound-assisted synthesis of 1, 8-dioxodecahydroacridine derivatives in presence of Ag doped CdS nanocatalyst

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1145-1158 | Received 27 Jan 2019, Accepted 28 Apr 2019, Published online: 22 May 2019
 

Abstract

CdS and Ag-doped CdS (Cd1-xAgxS, x = 0.02, 0.04 and 0.06) nanoparticles (NPs) with average Scherer’s sizes 9.9 nm, 9.6 nm, 10.5 nm and 12.8 nm, respectively, were successfully synthesized and systematically characterized using various experimental techniques. The catalytic activities of these NPs have been evaluated by an ultrasound assisted synthesis of fourteen 5(a-n) types of 1,8-dioxodecahydroacridine (DODHAs) derivatives via multi-component reaction (MCR) among dimedone (2 mmol), aryladehyde (1 mmol) and ammonium acetate (1 mmol) or aniline (1 mmol) or p-toluidine (1 mmol) in deionized water (DIW) at room temperature (RT) just in 15 min. Excellent yields and reusability of the catalyst up to six consecutive runs were remarkably obtained in each case; 89% being the highest yield for x = 0.06 compared to 20% yield of x = 0, indicating vividly the importance of Ag doping in CdS. Ag doping helps to increase the number of acidic sites enhancing the acidity as confirmed from NH3-TPD, zeta potential, conductivity and surface area of the catalysts. This methodology illustrates clearly a very facile procedure, with wide applicability, extending the scope to aliphatic and aromatic compounds as source for nitrogen in the synthesis of these acridines.

Graphical Abstract

Acknowledgements

Authors are thankful to the Center Director, Dr V. Ganesan, UGC-DAE Consortium for Scientific Research, Indore, India, for allowing us to utilize the available national facilities. We also thank Dr M. Gupta/Mr. Layanta Behra, Dr. D. M. Phase/Mr. V.K. Ahire and Dr. R. J. Choudhary/Mr. Avinash Wadikar, UGC-DAE CSR, Indore for providing XRD, EDAX, and XPS facilities, respectively.

Conflicts of interest

There are no conflicts to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.